Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NKTR on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
20.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7.24K
Holdings value
$412K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
7
Number of buys
3
Number of sells
-2
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $9.27M 12.5M BlackRock, Inc. 31 Mar 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.61% $4.92M 6.65M Eventide Asset Management, LLC 31 Dec 2024
Deep Track Capital, LP 1.07% $1.46M 1.98M Deep Track Capital, LP 31 Dec 2024

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 7.24K $412K +$300K $56.90 7
2025 Q2 6.45K $52.9K -$84.3M $25.84 7
2025 Q1 124M $84.2M -$9.62M $0.68 156
2024 Q4 133M $124M -$10.1M $0.93 144
2024 Q3 141M $183M +$5.56M $1.30 138
2024 Q2 135M $168M +$31.2M $1.24 132
2024 Q1 113M $105M -$4.64M $0.93 117
2023 Q4 119M $67.3M -$14.4M $0.57 119
2023 Q3 143M $85.3M +$3.47M $0.60 130
2023 Q2 138M $79.2M -$21.6M $0.58 138
2023 Q1 173M $121M -$6.85M $0.70 187
2022 Q4 169M $382M -$28.1M $2.26 209
2022 Q3 175M $562M -$30M $3.20 208
2022 Q2 182M $693M +$14.9M $3.80 203
2022 Q1 176M $947M -$12.6M $5.39 217
2021 Q4 174M $2.35B +$60.8M $13.51 225
2021 Q3 168M $3.01B -$15.3M $17.96 228
2021 Q2 168M $2.88B -$33.3M $17.16 231
2021 Q1 170M $3.39B -$52.8M $20.00 224
2020 Q4 172M $2.93B -$17M $17.00 232
2020 Q3 176M $2.92B -$42M $16.59 238
2020 Q2 175M $4.05B -$44.6M $23.16 249
2020 Q1 177M $3.16B +$12.3M $17.85 234
2019 Q4 176M $3.8B -$40.9M $21.58 270
2019 Q3 178M $3.24B +$139M $18.22 272
2019 Q2 166M $5.9B +$834M $35.58 327
2019 Q1 163M $5.47B -$66.8M $33.60 340
2018 Q4 165M $5.42B +$34.3M $32.87 322
2018 Q3 160M $9.73B -$26.5M $60.96 375
2018 Q2 160M $7.83B -$144M $48.83 368
2018 Q1 157M $16.7B +$351M $106.26 349
2017 Q4 155M $9.23B +$80.6M $59.72 261
2017 Q3 154M $3.69B +$66.5M $24.00 203
2017 Q2 151M $2.96B +$123M $19.55 196
2017 Q1 146M $3.43B +$472M $23.47 198
2016 Q4 145M $1.78B +$107M $12.27 196
2016 Q3 134M $2.29B -$7.29M $17.18 189
2016 Q2 134M $1.91B -$65.6M $14.23 171
2016 Q1 139M $1.91B -$6.78M $13.75 172
2015 Q4 139M $2.35B -$21.2M $16.85 177
2015 Q3 142M $1.55B +$30.9M $10.96 165
2015 Q2 138M $1.73B +$152M $12.51 177
2015 Q1 126M $1.39B +$59.7M $11.00 152
2014 Q4 120M $1.86B +$32.2M $15.50 162
2014 Q3 118M $1.43B +$50.5M $12.07 144
2014 Q2 114M $1.46B -$20.6M $12.82 141
2014 Q1 116M $1.4B +$165M $12.12 138